Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Smoking Cessation 3Smoking 2Neoplasms 2Lung Neoplasms 2Alcohol Drinking 2Urinary Bladder Neoplasms 1Smokers 1Postoperative Complications 1HIV Infections 1Cigarette Smoking 1Cigarette Smoker 1Carcinoma, Non-Small-Cell Lung 1Cancer Free Women 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Smoking Devices × Clear all
NCT05941858 2026-04-02

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled

Neoplasms, Smoking Cessation

NCT03668769 2024-02-23

Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking

M.D. Anderson Cancer Center

Phase NA Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡